Xu Jin, Chen Xue-Mei, Ma Chen-Kai, Wang Xiang-Rui
Department of Anesthesiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cochrane Database Syst Rev. 2014(12):CD010937. doi: 10.1002/14651858.CD010937.pub2. Epub 2014 Dec 11.
Major knee surgery is a common operative procedure to help people with end-stage knee disease or trauma to regain mobility and have improved quality of life. Poorly controlled pain immediately after surgery is still a key issue for this procedure. Peripheral nerve blocks are localized and site-specific analgesic options for major knee surgery. The increasing use of peripheral nerve blocks following major knee surgery requires the synthesis of evidence to evaluate its effectiveness and safety, when compared with systemic, local infiltration, epidural and spinal analgesia.
To examine the efficacy and safety of peripheral nerve blocks for postoperative pain control following major knee surgery using methods that permit comparison with systemic, local infiltration, epidural and spinal analgesia.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 1, 2014), MEDLINE and EMBASE, from their inception to February 2014. We identified ongoing studies by searching trial registries, including the metaRegister of controlled trials (mRCT), clinicaltrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP).
We included participant-blind, randomized controlled trials of adult participants (15 years or older) undergoing major knee surgery, in which peripheral nerve blocks were compared to systemic, local infiltration, epidural and spinal analgesia for postoperative pain relief.
Two review authors independently assessed study eligibility and extracted data. We recorded information on participants, methods, interventions, outcomes (pain intensity, additional analgesic consumption, adverse events, knee range of motion, length of hospital stay, hospital costs, and participant satisfaction). We used the 5-point Oxford quality and validity scale to assess methodological quality, as well as criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions. We conducted meta-analysis of two or more studies with sufficient data to investigate the same outcome. We used the I² statistic to explore the heterogeneity. If there was no significant heterogeneity (I² value 0% to 40%), we used a fixed-effect model for meta-analysis, but otherwise we used a random-effects model. For dichotomous data, we present results as a summary risk ratio (RR) and a 95% confidence interval (95% CI). Where possible, we calculated the number needed to treat for an additional beneficial outcome (NNTB) or for an additional harmful outcome (NNTH), together with 95% CIs. For continuous data, we used the mean difference (MD) and 95% CI for similar outcome measures. We describe the findings of individual studies where pooling of data was not possible.
According to the eligibility criteria, we include 23 studies with 1571 participants, with high methodological quality overall. The studies compared peripheral nerve blocks adjunctive to systemic analgesia with systemic analgesia alone (19 studies), peripheral nerve blocks with local infiltration (three studies), and peripheral nerve blocks with epidural analgesia (one study). No study compared peripheral nerve blocks with spinal analgesia.Compared with systemic analgesia alone, peripheral nerve blocks adjunctive to systemic analgesia resulted in a significantly lower pain intensity score at rest, using a 100 mm visual analogue scale, at all time periods within 72 hours postoperatively, including the zero to 23 hours interval (MD -11.85, 95% CI -20.45 to -3.25, seven studies, 390 participants), the 24 to 47 hours interval (MD -12.92, 95% CI -19.82 to -6.02, six studies, 320 participants) and the 48 to 72 hours interval (MD -9.72, 95% CI -16.75 to -2.70, four studies, 210 participants). Subgroup analyses suggested that the high levels of statistical variation in our analyses could be explained by larger effects in people undergoing total knee arthroplasty compared with other types of surgery. Pain intensity was also significantly reduced on movement in the 48 to 72 hours interval postoperatively (MD -6.19, 95% CI -11.76 to -0.62, two studies, 112 participants). There was no significant difference on movement between these two groups in the time period of zero to 23 hours (MD -6.95, 95% CI -15.92 to 2.01, five studies, 304 participants) and 24 to 47 hours (MD -8.87, 95% CI -27.77 to 10.03, three studies, 182 participants). The included studies reported diverse types of adverse events, and we did not conduct a meta-analysis on specific types of adverse event. The numbers of studies and participants were also too few to draw conclusions on the other prespecified outcomes of: additional analgesic consumption; median time to remedication; knee range of motion; median time to ambulation; length of hospital stay; hospital costs; and participant satisfaction. There were insufficient data to compare peripheral nerve blocks and local infiltration or between peripheral nerve blocks and epidural analgesia.
AUTHORS' CONCLUSIONS: All of the included studies reported the main outcome of pain intensity but did not cover all the secondary outcomes of interest. The current review provides evidence that the use of peripheral nerve blocks as adjunctive techniques to systemic analgesia reduced pain intensity when compared with systemic analgesia alone after major knee surgery. There were too few data to draw conclusions on other outcomes of interest. More trials are needed to demonstrate a significant difference when compared with local infiltration, epidural analgesia and spinal analgesia.
膝关节大手术是一种常见的手术操作,旨在帮助终末期膝关节疾病或创伤患者恢复活动能力并改善生活质量。术后疼痛控制不佳仍是该手术的一个关键问题。外周神经阻滞是膝关节大手术局部和部位特异性的镇痛选择。与全身、局部浸润、硬膜外和脊髓镇痛相比,膝关节大手术后外周神经阻滞的使用日益增多,这就需要综合证据来评估其有效性和安全性。
采用能与全身、局部浸润、硬膜外和脊髓镇痛进行比较的方法,研究外周神经阻滞用于膝关节大手术后疼痛控制的有效性和安全性。
我们检索了Cochrane对照试验中心注册库(CENTRAL)(2014年第1期)、MEDLINE和EMBASE,检索时间从各数据库建库至2014年2月。我们通过检索试验注册库来识别正在进行的研究,包括对照试验元注册库(mRCT)、clinicaltrials.gov和世界卫生组织国际临床试验注册平台(ICTRP)。
我们纳入了对成年参与者(15岁及以上)进行膝关节大手术的参与者盲法随机对照试验,其中将外周神经阻滞与全身、局部浸润、硬膜外和脊髓镇痛用于术后疼痛缓解进行比较。
两位综述作者独立评估研究的入选资格并提取数据。我们记录了有关参与者的数据、方法、干预措施、结局(疼痛强度、额外的镇痛药物使用、不良事件、膝关节活动范围、住院时间、住院费用和参与者满意度)。我们使用5分制牛津质量和有效性量表以及《Cochrane干预措施系统评价手册》中概述的标准来评估方法学质量。我们对两项或更多有足够数据以调查相同结局的研究进行荟萃分析。我们使用I²统计量来探讨异质性。如果没有显著异质性(I²值为0%至40%),我们使用固定效应模型进行荟萃分析,否则我们使用随机效应模型。对于二分数据,我们将结果表示为汇总风险比(RR)和95%置信区间(95%CI)。在可能的情况下,我们计算了获得额外有益结局(NNTB)或额外有害结局(NNTH)所需治疗的人数以及95%CI。对于连续数据,我们使用均值差(MD)和95%CI用于类似的结局测量。我们描述了无法合并数据的个别研究的结果。
根据入选标准,我们纳入了23项研究,共1571名参与者,总体方法学质量较高。这些研究将外周神经阻滞联合全身镇痛与单纯全身镇痛进行比较(19项研究)、外周神经阻滞与局部浸润进行比较(3项研究)以及外周神经阻滞与硬膜外镇痛进行比较(1项研究)。没有研究将外周神经阻滞与脊髓镇痛进行比较。与单纯全身镇痛相比,在术后72小时内的所有时间段,包括0至23小时(MD - 11.85,95%CI - 20.45至- 3.25,7项研究,390名参与者)、24至47小时(MD - 12.92,95%CI - 19.82至- 6.02,6项研究,320名参与者)和48至72小时(MD - 9.72,95%CI - 16.75至- 2.70,4项研究,210名参与者),使用100毫米视觉模拟量表,外周神经阻滞联合全身镇痛在静息时的疼痛强度评分显著更低。亚组分析表明,我们分析中的高水平统计变异可以通过全膝关节置换术患者与其他类型手术患者相比的更大效应来解释。术后48至72小时内活动时的疼痛强度也显著降低(MD - 6.19,95%CI - 11.76至- 0.62,2项研究,112名参与者)。在0至23小时(MD - 6.95,95%CI - 15.92至2.01,5项研究,304名参与者)和24至47小时(MD - 8.87,95%CI - 27.77至10.03,3项研究,182名参与者)这两个时间段内,两组在活动时的疼痛强度没有显著差异。纳入的研究报告了不同类型的不良事件,我们没有对特定类型的不良事件进行荟萃分析。研究数量和参与者数量也太少,无法就以下其他预先设定的结局得出结论:额外的镇痛药物使用;再次用药的中位时间;膝关节活动范围;下床行走的中位时间;住院时间;住院费用;以及参与者满意度。没有足够的数据来比较外周神经阻滞与局部浸润或外周神经阻滞与硬膜外镇痛之间的差异。
所有纳入的研究都报告了疼痛强度这一主要结局,但未涵盖所有感兴趣的次要结局。当前综述提供的证据表明,与单纯全身镇痛相比,外周神经阻滞作为全身镇痛的辅助技术在膝关节大手术后可降低疼痛强度。关于其他感兴趣的结局,数据太少无法得出结论。与局部浸润、硬膜外镇痛和脊髓镇痛相比,还需要更多试验来证明存在显著差异。